ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,754,000 | +89.7% | 63,798 | +52.9% | 0.01% | +66.7% |
| Q2 2021 | $3,561,000 | -24.5% | 41,721 | +1.5% | 0.00% | -40.0% |
| Q1 2021 | $4,718,000 | -16.3% | 41,102 | +2.1% | 0.01% | -16.7% |
| Q4 2020 | $5,638,000 | +52.6% | 40,274 | -11.2% | 0.01% | +50.0% |
| Q3 2020 | $3,694,000 | +2.0% | 45,350 | -10.0% | 0.00% | 0.0% |
| Q2 2020 | $3,623,000 | +101.3% | 50,412 | +24.6% | 0.00% | +100.0% |
| Q1 2020 | $1,800,000 | +72.1% | 40,461 | +268.7% | 0.00% | +100.0% |
| Q4 2019 | $1,046,000 | -34.7% | 10,973 | -46.0% | 0.00% | -50.0% |
| Q3 2019 | $1,601,000 | +201.5% | 20,326 | +65.8% | 0.00% | – |
| Q2 2019 | $531,000 | – | 12,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |